Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 25 Small Cell Lung Carcinoma 23 Leukemia 18 Lymphoma, Large B-Cell, Diffuse 17 Lung Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma, Non-Hodgkin 14 Lymphoma, Extranodal NK-T-Cell 11 Hodgkin Disease 10 Leukemia, Myeloid, Acute 8 Carcinoma, Non-Small-Cell Lung 8 Ovarian Neoplasms 7 Neuroblastoma 7 Lymphoma, Mantle-Cell 7 Burkitt Lymphoma 7 Recurrence 6 Lymphoma, T-Cell, Peripheral 6 Central Nervous System Neoplasms 6 Retinoblastoma 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphohistiocytosis, Hemophagocytic 5 Breast Neoplasms 5 Testicular Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Teratoma 3

Interventions

Ifosfamide 1 Ice 1 Etoposide 1 Craniospinal Irradiation 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Intracranial Germ Cell Tumors × Etoposide × Clear all

NCT01424839 2015-06-04

SIOPCNSGCTII

University Hospital Muenster

Phase 4 Unknown

Intracranial Germ Cell Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡